Here, we also found overexpression of AFAP1-AS1 in the basal subtype compared to the other breast cancer subtypes; however, our in silico survival analysis revealed that low AFAP1-AS1 expression is associated with a worse prognosis in patients with breast cancer of the basal subtype. This evidence concerns the gene AFAP1 and breast carcinoma.